PepGen (PEPG) Prepaid Assets (2021 - 2026)
PepGen (PEPG) posted Prepaid Assets of $2.0 million for Q1 2026, down 21.5% sequentially from $2.5 million in Q4 2025, and down 39.74% YoY from $3.3 million in Q1 2025.
Analysis
PepGen (PEPG) Prepaid Assets (2021 - 2026) Analysis & Trends
PepGen has reported Prepaid Assets for 6 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Prepaid Assets fell 39.74% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 39.74% YoY) and the FY2025 annual result came in at $2.5 million, down 29.78% from the prior year.
- Prepaid Assets retreated to $2.0 million in Q1 2026 per PEPG's latest filing, from $2.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $4.6 million in Q3 2022 and troughed at $2.0 million in Q1 2026.
- A 5-year average of $3.1 million and a median of $3.3 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 84.53% in 2022, then sank 47.56% in 2023.
- Over 5 years, Prepaid Assets stood at $4.3 million in 2022, then plunged by 47.56% to $2.3 million in 2023, then jumped by 57.2% to $3.6 million in 2024, then retreated by 29.78% to $2.5 million in 2025, then slipped by 21.5% to $2.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $2.0 million, $2.5 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.09 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Sep 30, 2024 | 3.51 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | 3.07 Mn |
| Dec 31, 2022 | 4.33 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 3.43 Mn |
| Mar 31, 2022 | 2.24 Mn |
| Dec 31, 2021 | 2.35 Mn |